10 April 2019 – marketing authorisation
Xonvea has gained marketing approval in the Republic of Ireland from the country’s medicines regulator, the Health Products Regulatory Authority, for the treatment of nausea and vomiting of pregnancy where conservative management has failed. This approval will allow the first launch of Xonvea outside the UK, where the product was in-licensed from Duchesnay Inc. of Canada in 2015 and launched in October 2018. It is expected that Xonvea will be launched in Ireland in the final quarter of 2019 and will be marketed directly by Alliance’s in-country sales and marketing team. We retain our BUY rating.